Cargando…

MTHFD2 promotes PD‐L1 expression via activation of the JAK/STAT signalling pathway in bladder cancer

Although combination chemotherapy is widely used for bladder cancer (BC) treatment, the recurrence and progression rates remain high. Therefore, novel therapeutic targets are required. Methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) contributes to tumourigenesis and immune evasion in several canc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Linzhi, Zhang, Yunlong, Hu, Weimin, Zou, Fan, Ning, Jinzhuo, Rao, Ting, Ruan, Yuan, Yu, Weimin, Cheng, Fan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10538262/ https://www.ncbi.nlm.nih.gov/pubmed/37480214 http://dx.doi.org/10.1111/jcmm.17863

Ejemplares similares

Anti-tumor effect of AZD8055 against bladder cancer and bladder cancer-associated macrophages
por: Hu, Weimin, et al.
Publicado: (2023)

SQLE Knockdown inhibits bladder cancer progression by regulating the PTEN/AKT/GSK3β signaling pathway through P53
por: Zou, Fan, et al.
Publicado: (2023)

Corrigendum to “Anti-tumor effect of AZD8055 against bladder cancer and bladder cancer-associated macrophages” [Heliyon 9(3) (March 2023) e14272]
por: Hu, Weimin, et al.
Publicado: (2023)

CALD1 promotes the expression of PD-L1 in bladder cancer via the JAK/STAT signaling pathway
por: Li, Cheng, et al.
Publicado: (2021)

Photobiomodulation With Blue Laser Inhibits Bladder Cancer Progression
por: Xia, Yuqi, et al.
Publicado: (2021)

Long noncoding RNA UCA1 targets miR-582-5p and contributes to the progression and drug resistance of bladder cancer cells through ATG7-mediated autophagy inhibition
por: Wu, Junfeng, et al.
Publicado: (2019)

Evaluation of aliphatic acid metabolism in bladder cancer with the goal of guiding therapeutic treatment
por: Song, Tianbao, et al.
Publicado: (2022)

Upregulation of MTHFD2 is associated with PD-L1 activation in bladder cancer via the PI3K/AKT pathway
por: Deng, Xinxi, et al.
Publicado: (2022)

Experience in management of emergency and severe cases of non-COVID-19 during the outbreak of COVID-19
por: Yu, Weimin, et al.
Publicado: (2021)

MTHFD2 promotes ovarian cancer growth and metastasis via activation of the STAT3 signaling pathway
por: Li, Qiutong, et al.
Publicado: (2021)

High-pressure carbon dioxide pneumoperitoneum induces oxidative stress and mitochondria-associated apoptotic pathway in rabbit kidneys with severe hydronephrosis
por: Zhao, Sheng, et al.
Publicado: (2019)

Expression and Role of Methylenetetrahydrofolate Dehydrogenase 1 Like (MTHFD1L) in Bladder Cancer
por: Eich, Marie-Lisa, et al.
Publicado: (2019)

MTHFD1L-Mediated Redox Homeostasis Promotes Tumor Progression in Tongue Squamous Cell Carcinoma
por: Li, Hao, et al.
Publicado: (2019)

Interleukin-6 promotes proliferative vitreoretinopathy by inducing epithelial-mesenchymal transition via the JAK1/STAT3 signaling pathway
por: Chen, Xiaoyun, et al.
Publicado: (2020)

The folate cycle enzyme MTHFD2 induces cancer immune evasion through PD-L1 up-regulation
por: Shang, Man, et al.
Publicado: (2021)

Identification and Validation of Hub Genes Associated with Bladder Cancer by Integrated Bioinformatics and Experimental Assays
por: Chen, Kang, et al.
Publicado: (2021)

Prognostic and immunological roles of IL18RAP in human cancers
por: Chen, Wu, et al.
Publicado: (2023)

Non‐metabolic function of MTHFD2 activates CDK2 in bladder cancer
por: Liu, Xi, et al.
Publicado: (2021)

PD‐L1 expression is mainly regulated by interferon gamma associated with JAK‐STAT pathway in gastric cancer
por: Mimura, Kousaku, et al.
Publicado: (2017)

Comprehensive analysis reveals XCL2 as a cancer prognosis and immune infiltration-related biomarker
por: Chen, Wu, et al.
Publicado: (2023)

Biocompatibility and efficacy of prostatic urethral lift in benign prostate hyperplasia: an in vivo and in vitro study
por: Xia, Yuqi, et al.
Publicado: (2023)

Immunosuppressive effect of bladder cancer on function of dendritic cells involving of Jak2/STAT3 pathway
por: Xiu, Weigang, et al.
Publicado: (2016)

Association of Maternal Folate Intake and Offspring MTHFD1 and MTHFD2 Genes with Congenital Heart Disease
por: Liu, Hanjun, et al.
Publicado: (2023)

The Drosophila JAK-STAT pathway
por: Zeidler, Martin P, et al.
Publicado: (2013)

Evolution of the JAK-STAT pathway
por: Liongue, Clifford, et al.
Publicado: (2013)

The JAK-STAT pathway at 20
por: Darnell, Jr., James E.
Publicado: (2012)

MTHFD2- a new twist?
por: Tedeschi, Philip M., et al.
Publicado: (2016)

SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/β‐catenin pathway
por: Chen, Wu, et al.
Publicado: (2021)

BMAL1 regulates mitochondrial homeostasis in renal ischaemia‐reperfusion injury by mediating the SIRT1/PGC‐1α axis
por: Ye, Peng, et al.
Publicado: (2022)

Construction and Analysis of Immune Infiltration-Related ceRNA Network for Kidney Stones
por: Xia, Yuqi, et al.
Publicado: (2021)

An overview of JAK/STAT pathways and JAK inhibition in alopecia areata
por: Lensing, Maddison, et al.
Publicado: (2022)

Paeoniflorin protects PC12 cells from oxygen-glucose deprivation/reoxygenation-induced injury via activating JAK2/STAT3 signaling
por: Zhang, Zhuo, et al.
Publicado: (2021)

JAK-STAT pathway and myogenic differentiation
por: Jang, You-Na, et al.
Publicado: (2013)

JAK-STAT Signalling Pathway in Cancer
por: Brooks, Andrew J., et al.
Publicado: (2020)

JAK-STAT pathway inhibitors in dermatology()
por: Miot, Hélio Amante, et al.
Publicado: (2023)

Classification and clinical significance of the posterior group of renal calyces
por: Qi, Yucheng, et al.
Publicado: (2023)

TFAP2C Knockdown Sensitizes Bladder Cancer Cells to Cisplatin Treatment via Regulation of EGFR and NF-κB
por: Xing, Ji, et al.
Publicado: (2022)

Protein Inhibitor of Activated STAT (PIAS) Negatively Regulates the JAK/STAT Pathway by Inhibiting STAT Phosphorylation and Translocation
por: Niu, Guo-Juan, et al.
Publicado: (2018)

MiR-425 Promotes Migration and Invasion in Bladder Cancer by Targeting Dickkopf 3
por: Ning, Jin-zhuo, et al.
Publicado: (2020)

JAKs and STATs in chemoresistance
por: Costa-Pereira, Ana P
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_32oc9fr5hq0qps65ir2nko7do2